Prothena Corporation plc

PRTA ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A May 11, 2026
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
4 Apr 10, 2026
3 Apr 10, 2026
ARS Mar 27, 2026 ARS
DEFA14A Mar 27, 2026 DEFA14A
DEF 14A Mar 27, 2026 DEF 14A
4 Mar 5, 2026
4 Mar 5, 2026
4 Mar 5, 2026
4 Mar 5, 2026
4 Mar 5, 2026
4 Mar 5, 2026
4 Mar 5, 2026
EFFECT Mar 2, 2026
8-K Feb 27, 2026 8-K
POS AM Feb 27, 2026 POS AM
10-K Feb 27, 2026 10-K
POSASR Feb 27, 2026 POSASR
8-K Feb 19, 2026 8-K
SCHEDULE 13G Feb 13, 2026
8-K Dec 12, 2025 8-K
8-K Nov 19, 2025 8-K
SCHEDULE 13G/A Nov 14, 2025
← Newer Page 3 of 42 · 1026 filings Older →